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Abstract
The Gram-negative bacterium Pseudomonas aeruginosa is an important opportunistic pathogen in compromised
individuals, such as patients with cystic fibrosis, severe burns or impaired immunity. In this work we aimed to screen
novel essential genes of P. aeruginosa by shotgun antisense identification, a technique that was developed a decade ago for
the Gram-positive bacterium Staphylococcus aureus and was under-used in Gram-negative bacteria for a considerable
period of time. Following antisense screenings in the PAO1 strain of P. aeruginosa, we focused on a locus, PA2873, which
was targeted by an antisense RNA construct that can impair cell growth. The PA2873 gene product was annotated as a
hypothetical membrane protein endowed with a periplasmic region harbouring a structural domain belonging to the
transglutaminase-like superfamily, a group of archaeal, bacterial and eukaryotic proteins homologous to animal
transglutaminases. In this study, we show that the periplasmic portion of the PA2873 protein, which we named TgpA,
does possess transglutaminase activity in vitro. This is the first report of transglutaminase activity in P. aeruginosa. In
addition, we have provided strong evidences that TgpA plays a critical role in the viability of P. aeruginosa.
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Introduction
P. aeruginosa is a highly adaptable bacterium which thrives in a
broad range of ecological niches. In addition, it can infect multiple
hosts as diverse as plants, nematodes and mammals. The broad
habitat and host ranges of P. aeruginosa reflect the large variety of
structural, metabolic and virulence functions found in its large
pangenome [1–4]. In humans, it is an important opportunistic
pathogen in compromised individuals, such as patients with cystic
fibrosis, severe burns or impaired immunity [5,6]. Unfortunately,
P. aeruginosa is difficult to control because of its ability to develop
resistances, often multiple, to all classes of clinical antibiotics [7–9].
The common P. aeruginosa mechanisms of antibiotic resistance
often appear simultaneously and are cephalosporinase AmpC-,
porin OprD- and efflux pumps-mediated [8]. Consequently, P.
aeruginosa is a major concern to medical practitioners who
increasingly face extremely-drug resistant strains (i.e. bacterial
isolates susceptible to only one or two antibiotic categories) [9]
which may require carefully-selected antibiotic combinations [10].
The discovery of novel essential genes or pathways that have not
yet been targeted by clinical antibiotics can underlie the
development of alternative effective antibacterials to overcome
the extant mechanisms of resistance. We screened novel essential
genes of P. aeruginosa by shotgun antisense identification, a
technique that was developed a decade ago in Staphylococcus aureus
[11,12]; following a period of limited success in Gram-negative
bacteria [13,14], the technique has been used effectively in E. coli
[15]. Following our shotgun antisense screenings in P. aeruginosa
PAO1, we focused on a locus, PA2873, which was targeted by an
antisense RNA construct that can impair cell growth. The features
of the predicted protein encoded by PA2873 locus were intriguing.
In fact, it was annotated in the Pseudomonas Genome Database
[16] as a hypothetical membrane protein endowed with a
periplasmic region harbouring a structural domain belonging to
the transglutaminase-like superfamily, a group of archaeal,
bacterial and eukaryotic proteins homologous to animal transglu-
taminases [17]. In this study we show that the periplasmic portion
of the PA2873 protein does have transglutaminase activity in vitro.
This is the first report of a transglutaminase activity in P. aeruginosa.
The PA2873 gene product was called ‘‘transglutaminase protein
A’’ (TgpA). In addition, we provided strong evidences that TgpA
plays a critical role in the viability of P. aeruginosa.
Methods
Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used are listed in Table S1.
pVLT31 [18] is an E. coli/Pseudomonas shuttle vector carrying the
lacIq/Ptac pair and tetracycline resistance. pVI533EH [19] and
pHERD20T [20], used for the construction of antisense libraries
(see below), are E. coli/Pseudomonas shuttle vectors carrying araC/
PBAD pair and ampicillin/carbenicillin resistance. Since
pHERD20T allows blue/white screening for the identification of
recombinants, it was used in place of pVI533EH at later stages of
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antisense libraries preparation. pVI533HE is a pVI533EH twin-
plasmid carrying the polylinker sequence in opposite orientation
downstream PBAD promoter. pDM4 [21] is a suicide plasmid in
Pseudomonas species carrying the chloramphenicol resistance.
pVLT31-M4G6 and pVI533HE-M4G6i were obtained by cloning
the EcoRI-HindIII insert of pVI533EH-M4G6, identified in the
antisense libraries screenings, into pVLT31 and pVI533HE,
respectively. pVLT31-M4G6i was obtained by cloning a Hin-
dIII-EcoRI fragment amplified by PCR from pVI533EH-M4G6
with primers M4G6Hind59 and M4G6Eco39 (Table S2) into
pVLT31. PCR reactions were performed using DreamTaq
Polymerase (Fermentas) with the addition of 1 M betaine (Sigma
Aldrich), because of the high GC content of P. aeruginosa genome.
Bacteria were grown at 37uC in Luria–Bertani (LB) broth, or in
M9 minimal medium supplemented with 0.2% citrate (M9-
citrate). Antibiotics were added at the following concentrations
(mg/ml): carbenicillin (Cb) 300; kanamycin (Km) 50; chloram-
phenicol (Cm) 30 and 85 for E. coli and P. aeruginosa, respectively;
tetracycline (Tc) 25; gentamicin (Gm) 25 and 50 for E. coli and P.
aeruginosa, respectively. Arabinose, rhamnose, glucose and IPTG
were used at concentrations of 7.5 mM, 0.2%, 1%, and 1 mM,
respectively. In mating experiments, exconjugant P. aeruginosa
PAO1 clones were selected on Pseudomonas Isolation Agar (PIA;
Difco) with an appropriate antibiotic or on M9-citrate in case of
use of tetracycline.
Construction and screening of PAO1 shotgun antisense
libraries
Shotgun antisense libraries (SALs) of P. aeruginosa PAO1 were
constructed in E. coli into pVI533EH and pHERD20T as
described previously [11,12]. To screen for genomic fragments
interfering with PAO1 growth, SALs were mobilized from E. coli
to PAO1 by conjugative triparental mating. PAO1 exconjugant
cell spots were inspected for growth defects after 24–48 hrs of
incubation at 37uC, both in the presence and in the absence of
arabinose. The inserts pVI533EH and pHERD20T derivatives
impairing recipient PAO1 growth were sequenced after PCR
amplification using oligo pairs pVI533F/pVI533R and pHERD-
F/pHERD-R for pVI533EH and pHERD20T, respectively
(Table S2).
Identification of PA2873 gene product in P. aeruginosa
membrane fractions
P. aeruginosa PAO1 cells, grown in LB with aeration at 37uC
until OD600 of 0.6, were harvested by centrifugation at 40006g for
15 min at 4uC and washed twice with PBS supplemented with
20% sucrose (TIB buffer). PAO1 cells in TIB buffer were disrupted
in a French press device. To remove intact cells that had escaped
lysis, crude extracts were filtered through 0.22 mm filters.
Following incubation for 1 hr at room temperature with RNase
A (Qiagen) and DNase I (Ambion), filtered crude extracts were
ultracentrifuged at 135,0006g for 60 min at 4uC to separate total
membranes from the cytoplasmic fraction. Pellets containing the
membrane fraction were washed in sequence with PBS, 1 M
NaCl, and water to remove the contaminants; they were treated
overnight under stirring with 40 mg/ml trypsin at 37uC for shaving
and the extensive peptide proteolysis required for the Multidi-
mensional Protein Identification Technology (MudPIT) analysis.
Trypsin-digested samples were centrifuged at 16,0006g for 1 hr at
4uC and the supernatants were subjected to MudPIT analysis
using the ProteomeX configuration (Thermo Fisher, San Jose`, CA,
USA). The mass spectra produced by MudPIT analyses were
correlated to in silico peptide sequences of non-redundant P.
aeruginosa protein database (5753 entries) retrieved from NCBI
(http://www.ncbi.nlm.nih.gov/). Data processing of raw spectra
was performed by the Bioworks 3.3.1 software (University of
Washington, licensed to Thermo Fisher Scientific), based on the
SEQUEST algorithm [22].
Purification of TgpA TG180–544 domain and
transglutaminase activity assay
The TgpA periplasmic domain (aa. 180–544; TG180–544) was
expressed in E. coli as N(His)10-tagged protein with an improved
His-tag (MGSDKIHHHHHHHHHHGV) under the control of
T7 promoter in plasmid p2N[M4G6 (180–544 aa)] (PRIMM srl),
and purified using standard protocols of His-tag affinity purifica-
tion. The fractions containing TG180–544 were pooled and stored
at 280uC until use in aliquots at the concentration of 2.7 mg/ml
and 95% purity, determined by SDS-PAGE.
Transglutaminase activity (TGase; EC 2.3.2.13) was assayed by
a Transglutaminase Colorimetric Microassay Kit (Covalab) which
uses immobilized N-carbobenzoxy(CBZ)-Gln-Gly as amine accep-
tor and biotin-conjugated cadaverine as amine donor. Protein
samples were incubated in a 96-well microtiter plate coated with
CBZ-Gln-Gly at 37uC for 15 min with calcium, DTT and
biotinylated cadaverine. The wells were washed three times with
phosphate buffer containing 0.1% Tween 20. To assay the
formation by TGase of cadaverine covalently linked to CBZ-Gln-
Gly (c-glutamyl-cadaverine-biotin), the wells were filled with
streptavidin-labelled horseradish peroxidase (HRP) and incubated
for 15 min at 37uC; they were washed three times with phosphate
buffer containing 0.1% Tween 20, filled with HRP substrate/
chromogen solution containing H2O2 as the substrate and
tetramethyl benzidine as the electron acceptor (chromogen).
These were incubated for 10 min at room temperature, 50 ml of
reaction blocking reagent were added and the mixture quantified
by measuring OD450. As references for the TGase activity, the kit
included purified guinea pig TGase with a specific activity of
0.1 U/mg. By definition, 1 U of TGase catalyzes the formation of
1 mmole of hydroxamate at pH 6.0 at 37uC, using L-glutamic acid
c- monohydroxamate as the standard [23].
RT-PCR analysis of PA2873 genomic region and transcript
59-end mapping
Total RNA was purified from P. aeruginosa PAO1 cells, grown in
LB with aeration at 37uC until OD600 of 0.6 (mid-exponential
phase) or of 1.2 (early stationary phase) was achieved using
RNeasy Mini kits (Qiagen) that included DNase I treatment.
Residual DNA was removed from purified RNA by further
treatment with RNA-free DNase I (Ambion) at 37uC for 15 min,
followed by DNase I inactivation with 2.5 mM EDTA at 65uC for
10 min. cDNA was generated by incubating 1 mg of RNA with
Superscript II Reverse Transcriptase (RT) (Invitrogen), 100 pg of
random primers (Invitrogen) and buffer supplied by the manufac-
turer for 50 min at 42uC. RT was inactivated by incubation at
70uC for 15 min. As a control of DNA contamination in the
subsequent RT-PCR analysis, reactions were also run without RT.
RT-PCR analysis was performed with the oligo pairs listed in
Table S2.
For mapping 59-ends of transcripts upstream PA2873 locus, a
primer extension assay was performed on PAO1 total RNA with
oligo 2873_PE60 (Table S2) end-labelled using [c-32P]-dATP
(3000 Ci mmol21) and polynucleotide kinase (Promega). 50 mg of
total RNA were mixed with 10 units of RNasin (Promega) and
1 pmol of 32P-2873_PE60 in a final volume of 10 ml of SS
hybridization buffer (300 mM NaCl, 10 mM Tris-HCl pH 7.5,
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2 mM EDTA). Reactions were heated at 80uC for 4 min,
incubated at 55uC for 2 hrs, diluted with pre-heated RT-buffer
(1 mM dNTPs, 10 mM DTT, 12.5 mM Tris-HCl pH 8.0,
7.5 mM MgCl2, 1 M betaine, 5 U of RNasin and 100 U of
SuperScript III RT) to a final volume of 50 ml, incubated at 50uC
for 30 min, and stopped with 1 ml of 0.5 M EDTA and 6 ml of
1 M NaOH at 55uC for 1 hr. Samples were neutralized with 6 ml
of 1 M HCl, precipitated, resuspended in Stop Solution (50%
formamide, 5 mM EDTA, 0.05% bromophenol blue and 0.05%
xylene cyanol), and electrophoresed on 50% urea, 6% acrylam-
ide/bis-acrylamide (19:1) gels in TBE buffer. Reference DNA
sequencing reaction was generated using as template a DNA
fragment amplified from PAO1 genomic DNA by PCR with oligo
pair SeqF/SeqR (Table S2). The DNA sequencing reaction was
performed with the fmol DNA Cycle Sequencing System
(Promega) with the addition of 1 M betaine.
Mutagenesis analyses
For pDM4 cointegration targeting, internal 600–800 bp DNA
fragments of PA2875, PA2874, PA2873, dnaG and algR, respec-
tively, were amplified by PCR with oligo pairs containing SalI
restriction sites listed in Table S2, digested with SalI (New England
Biolabs) and cloned into the corresponding site of pDM4. The
cloning was checked by PCR with the oligo pair pDM4-ori/
pDM4-cat (Table S2). This procedure gave rise to pDM4
derivatives listed in Table S1 which were transferred from E. coli
to P. aeruginosa PAO1 by triparental mating (see above for details)
selecting exconjugant PAO1 clones carrying pDM4 cointegration
on PIA plates supplemented with Cm.
The conditional mutagenesis of PA2873 locus was obtained
through upstream insertion of the rhamnose-induced/glucose-
repressed PrhaB promoter. The first 300 bp of PA2873 were
amplified by PCR with TgFullFw and Tg300RevXbaI oligos
(Table S2) carrying NdeI and XbaI sites, respectively. The resulting
DNA fragment was digested with NdeI and XbaI (New England
Biolabs) and cloned into the corresponding sites of the vector
pSC200, giving rise to the plasmid pSC200-PA2873, which was
mobilized to P. aeruginosa PAO1 by triparental mating. Exconju-
gant PAO1 clones carrying pSC200-PA2873 cointegration were
selected on PIA plates supplemented with Gm and rhamnose. One
such clone, named PAO1 PrhaB::PA2873, was grown overnight in
20 ml of M9-citrate, Gm and rhamnose as the PrhaB inducer at
37uC with shaking. Cells were collected through centrifugation at
13,000 rpm, washed twice with PBS, and resuspended in a
suitable volume of PBS to reach an OD600 of 1. To test the effects
of PrhaB promoter modulation on growth, the cell suspension was
used to inoculate, with a 106 -fold dilution, M9-citrate supple-
mented with Gm, and either with rhamnose (M9-citrate-rham-
nose) or glucose (M9-citrate-glucose). 200 ml aliquots of PAO1
PrhaB::PA2873-inoculated M9-citrate-rhamnose and M9-citrate-
glucose were distributed in triplicates in ‘‘Well Optical Bottom’’
96-wells microplates (Nunc, Thermo Fisher Scientific) and
incubated for 21 hrs in a Sunrise microplate reader (TECAN
Group Ltd.) at 37uC with constant shaking and real time OD
measurement at 595 nm every 15 min. In parallel, to test PAO1
PrhaB::PA2873 growth on a solid medium, the cell suspension in
PBS at OD600 of 1 was serially diluted up to 10
27 and spotted on
solid M9-citrate with Gm, in the presence of rhamnose or glucose.
Results and Discussion
Identification of an antisense construct targeting PA2873
locus and impairing PAO1 growth
To identify novel essential genes in P. aeruginosa, we constructed
shotgun antisense libraries (SALs) in E. coli by cloning genomic
DNA fragments of P. aeruginosa PAO1 downstream the arabinose
inducible promoter PBAD of pVI533EH or pHERD20T. Genomic
inserts able to impair PAO1 growth, supposedly by antisense
transcription effects, were screened by mating transfer of SALs
from E. coli to PAO1 and replica-plating of exconjugants on
Pseudomonas Isolation Agar (PIA) supplemented with carbenicil-
lin, both in the absence and in the presence of arabinose. These
screenings resulted in the identification of several positive
pVI533EH and pHERD20T derivatives impairing PAO1 growth
when transferred from E. coli (manuscript in preparation). As
expected, some positives of this panel carried inserts corresponding
to already known ‘‘essential-for-growth’’ genes. For instance, in the
pHERD20T derivative pHERD-S2F1, in antisense orientation,
we detected a 331 bp DNA fragment that spanned from
coordinates 637810 to 638141 of PAO1 genome, within the
PA0577 locus coding for DnaG primase [24].
For a number of positives to SALs screenings, growth
impairment was also observed in the absence of arabinose,
suggesting that basal antisense expression of the insert in PAO1, a
regulatory context for PBAD not as restrictive as E. coli, was enough
to produce deleterious effects. One such pVI533EH derivative,
pVI-M4G6 (Figure 1), was further characterized in this study. The
insert of pVI-M4G6 was sequenced and found to correspond to a
PAO1 genomic fragment spanning coordinates 3226136 to
3226491 within PA2873 locus (from 898 to 1252 positions;
PA2873 total length: 2007 bp), which inserted downstream to
the PBAD promoter of pVI533EH in antisense orientation. To
assess the antisense effect, the insert of pVI-M4G6 was inverted to
give rise to pVI-M4G6i and then retested for PAO1 growth
impairment. As shown in Figure 1, unlike pVI-M4G6, pVI-
M4G6i was unable to impair PAO1 growth once it had been
transferred from E. coli. To rule out effects of sensitization to Cb,
pVI-M4G6 insert was recloned into the TetR vector pVLT31 [18],
downstream to the Ptrp-lac promoter, both in antisense and sense
orientations, giving rise to pVL-M4G6 and pVL-M4G6i, respec-
tively. As in the case of pVI533EH, only the antisense expression
of insert from pVLT31 again resulted in PAO1 growth
impairment (Figure 1). These results strongly suggested that pVI-
M4G6-induced growth impairment of PAO1 originated from the
expression of a transcript of about 350 nt antisense to PA2873
locus. We therefore speculated that the PA2873 locus could code for
a novel and uncharacterized essential function of PAO1.
Features of PA2873 gene product, locus and genomic
region
Bioinformatic analyses, listed in Pseudomonas Genome Data-
base (PGD) [16], on the structural features of the PA2873 product
(688 aa; Figure 2A), predict that it is an inner membrane protein
endowed with six transmembrane helices and a large periplasmic
domain between aa 180 and 544 (Figure S3); between aa 396 and
467, it has a highly recognizable structural sub-domain belonging
to the transglutaminase-like superfamily (PF01841 in PFAM
database [25]), a group of archaeal, bacterial and eukaryotic
proteins homologous to animal transglutaminases [17] (Figure S1).
It is interesting to note that the 5 transmembrane helices spanning
the first 180 aa were within the bacterial domain of unknown
function DUF3488 (PF11992 in the PFAM database [25]),
typically between 323 to 339 amino acids in length and found to
TgpA, Novel Essential Protein in P. aeruginosa
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be associated with PF01841. Figure S2 illustrates the distribution
among prokaryotic species of protein presenting the association of
PF01841 transglutaminase domain and DUF3488.
Unfortunately, the PA2873 product was annotated in PGD as a
‘‘hypothetical protein’’, i.e. no experimental evidence of in vivo
expression was available and thus its existence had only been
predicted during bioinformatic genome analysis. To provide
evidence of PA2873 product expression, we searched a peptide
database that resulted from our recent proteomic survey in PAO1
(unpublished) and found five peptides belonging to the PA2873
periplasmic domain (Table S3), originating from the trypsin
digestion of native membrane fractions. Consequently, we have
provided experimental evidence that removes the PA2873 product
from the status of ‘‘hypothetical protein’’. Since all five PA2873
peptides ‘‘shaved’’ by trypsin belonged to the predicted outside
membrane domain, this strongly supports the notion that it
actually emerges from membrane itself.
The presence of a transglutaminase-like domain (TG) in
PA2873 protein was intriguing. Transglutaminases (TGases) are
enzymes that establish covalent links between proteins through the
acyl-transfer reaction between the c-carboxamide group of
peptide-bound glutamine and the e-amino group of peptide-
bound lysine. Catalysis of this reaction involves a catalytic triad
consisting of cysteine, histidine and aspartate residues that are
well-conserved in eukaryotic and prokaryotic TGases [17]. First of
all, we verified the conservation of the catalytic triad in the
PA2873 TG domain by sequence alignment with characterized
members of the TGase superfamily: the human coagulation factor
XIII conserved domain [26], TGase from red sea bream liver
(fish-derived transglutaminase, FTG) [27] and WbmE, a periplas-
mic TGase of Bordetella bronchiseptica [28] involved in the post-
assembly modification of LPS O-antigen. As shown in Figure 2A,
the catalytic triad of PA2873 TG domain appeared to be well-
conserved. To assess whether the conservation of the catalytic
triad was correlated to the TGase activity, the N-(His)10-tagged
periplasmic domain (aa 180–544) of PA2873 protein (TG180–544)
was expressed in E. coli and subjected to affinity purification.
TGase activity of the purified protein was tested through a
colorimetric microassay, using 0.25 mU of purified guinea pig
TGase (gpTGase) as the reference enzyme activity (Figure 2B).
Negative control of TGase activity was gpTGase incubated with
EDTA. TG180–544 was positive to the TGase test. In actual fact,
2.5 mg of TG180–544, equal to reference gpTGase, showed TGase
activity that differed significantly from the negative control and
was about 45% of gpTGase activity in the absence of EDTA. To
test activity dependence from Ca2+, essential for eukaryotic
TGases [27], EDTA was added to TG180–544. Unlike gpTGase,
EDTA addition did not affect TG180–544 activity. This suggested
that PA2873 TGase activity is Ca2+-independent, similar to
members of the microbial transglutaminase family [29]. For the
features described above, we called the PA2873 gene product
‘‘transglutaminase protein A’’ (TgpA).
In PGD, PA2873 locus was predicted to cluster in an operon
with the adjacent loci PA2875, PA2874 and PA2872 (Figure 3A).
This cluster arrangement is conserved throughout the sequenced
P. aeruginosa strains with the exception of strain 39016, where there
is a 354 bp intergenic region between PA2873 and PA2872
orthologs. When sequenced-Pseudomonas species in PGD were
examined, it was found in P. fulva, P. mendocina, P. syringae and P.
stutzeri strains. In the latter case, the PA2872 ortholog was absent.
To profile the transcription of PA2875-2874-2873-2972 pre-
dicted operon, we performed RT-PCR experiments on total
RNAs purified from PAO1 cell samples, taken both at mid-
exponential (OD600 of 0.6) and at early-stationary phase (OD600 of
1.2) in LB at 37uC. To detect single ORF transcription, we used
oligo pairs which amplified ORF internal regions (i, iii, v, and vii;
Figure 3B). Furthermore, to detect ORF cotranscription, we used
oligo pairs which amplified regions spanning the 39 to 59 of
adjacent ORFs (ii, iv, and vi; Figure 3B). As shown in Figure 3B,
we could observe transcription of every ORF in both growth
stages. Furthermore, our data strongly suggested that PA2875,
PA2874 and PA2873 are co-transcribed and form a transcription
unit, while PA2872 is transcribed independently.
Mutagenesis of the PA2875-2874-2873 gene cluster
The essential role of PA2873 locus (tgpA), suggested by the results
of SALs screenings (see above), was validated by insertional
mutagenesis. Consequently, we also aimed to evaluate the essential
role of the co-transcribed PA2875 and PA2874 loci. For this
reason, each gene was targeted for knock-out by homologous
recombination-mediated cointegration of the suicide vector pDM4
carrying Cm resistance (CmR). Since pDM4 is incapable of
autonomous replication in PAO1, following conjugational transfer
of pDM4 from E. coli to PAO1, CmR clones can be selected only in
the event of pDM4 cointegration with the chromosome. The dnaG
gene for DNA primase [24] and algR gene for a LytTR-type two-
component response regulator [30] were used as positive and
negative controls of essentiality, respectively. For cointegration
targeting, we cloned internal 600–800 bp fragments of PA2875,
PA2874, tgpA, dnaG and algR respectively, into pDM4. The
resulting constructs were transferred from E. coli S17-lpir to
PAO1 by conjugation, selecting cointegration events by plating the
conjugation mixtures on PIA supplemented with Cm. Three
independent conjugation experiments were performed for each
gene involved. To take fluctuations of conjugation efficiency into
Figure 1. Analysis of the growth impairment elicited by the
M4G6 insert resulting from SALs screenings. E. coli donors
harbouring the pVI533-based vectors pVI-M4G6 and pVI-M4G6i, which
carry downstream PBAD promoter the M4G6 insert in antisense and
sense orientation, respectively, were mated with P. aeruginosa PAO1
and exconjugants were spotted onto PIA to counterselect E. coli cells.
The medium was also supplemented with carbenicillin to select for
pVI533 maintenance. As a control, empty pVI533 was transferred to
PAO1 with the same procedure. Induction of PBAD promoter was
achieved through the addition of 7.5 mM arabinose (ara). A similar
protocol, with the only variant of M9-citrate for donor counterselection,
was used for the transfer to PAO1 of pVLT31-based vectors pVLT31-
M4G6 and pVLT31-M4G6i, and empty pVLT31. Induction of pVLT31 Ptac
promoter was achieved through the addition of 1 mM IPTG.
doi:10.1371/journal.pone.0050323.g001
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account, the results of replicate experiments were expressed as a
percentage of CmR ex-conjugant clones relative to the negative
control algR. As shown in Figure 4A, targeting pDM4 cointegra-
tion to both PA2874 and tgpA gave rise to a dramatic decrease in
the yield of CmR ex-conjugant clones, comparable to dnaG
inactivation. On the contrary, targeting pDM4 cointegration to
PA2875 resulted in a yield of CmR ex-conjugants that was even
higher than the control algR.
Figure 2. Predicted domain organization and transglutaminase activity of TgpA protein. (A) Map of the predicted domains DUF3488
(PF11992) and TG (PF01841) along the primary sequence of the PA2873 gene product, called TgpA. The sequence of TgpA spanning aa 396 to 467 of
the TG domain is highlighted and aligned to homologous functional TG domains of human coagulation Factor XIII, fish-derived transglutaminase
(FTG) and WbmE protein from B. bronchiseptica. Conserved aminoacids of catalytic triad are indicated by an asterisk. (B) Colorimetric assay of
transglutaminase activity of purified TgpA TG180–544 domain by Transglutaminase Colorimetric Microassay Kit (TCM kit; Covalab). TCM kit uses
immobilized N-carbobenzoxy(CBZ)-Gln-Gly as the amine acceptor and biotin-conjugated cadaverine as the amine donor. The indicated amounts of
purified TgpA TG180–544 (stock: 2.7 mg/ml, 95% purity) were incubated in 96-well microtiter plate coated with CBZ-Gln-Gly at 37uC for 15 min with
calcium, DTT and biotinylated cadaverine, both in the presence and the absence of EDTA supplied in the kit. As a reference for TGase activity, the
indicated amounts of kit-included purified guinea pig TGase with specific activity of 0.1 U/mg were incubated under the same conditions. The wells
were washed extensively and filled with streptavidin-labelled horseradish peroxidase (HRP) to assay the formation of immobilized c-glutamyl-
cadaverine-biotin by OD450 measurement of HRP activity using H2O2 as substrate and tetramethyl benzidine as electron acceptor (chromogen).
doi:10.1371/journal.pone.0050323.g002
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These results strongly support the notion that tgpA is essential. In
the case of PA2874, the above results were not conclusive. In
actual fact, the low yield of CmR ex-conjugant clones may result
either from the essential role of PA2874 or from polar effects of the
cointegration in PA2874 on the expression of tgpA. We were
unable to discriminate these two possibilities by targeting pDM4
cointegration within PA2874 in a PAO1 strain expressing tgpA
from a plasmid vector. Several attempts to introduce the tgpA-
expressing vector pVLT31-PA2873 into PAO1 were unsuccessful.
Therefore, we suggested that unbalancing the tgpA expression may
be deleterious. Finally, PA2875 would appear to be non-essential.
Using RT-PCR, we profiled the PA2875-2874-tgpA gene cluster
transcription in a CmR ex-conjugant strain PAO1
PA2875::pDM4, both upstream and downstream of the site of
pDM4 insertion within PA2875. As shown in Figure 3B, we could
detect transcription both upstream (i; PA2875) and downstream of
pDM4 cointegration in PA2875 (i39), in PA2874 (iii) and in tgpA
(v), respectively. Therefore, we validated the lack of polar effects of
the pDM4 cointegration in PA2875. Furthermore, these results
strongly suggested the presence of promoter(s) downstream of the
site of pDM4 insertion within PA2875. By primer extension
analysis with an oligo annealing with 59 region of tgpA (not shown),
we could detect 59 transcript ends located at 231, around 2280
and 2335 from the translation start site of tgpA.
The essentiality of tgpA was further confirmed by conditional
mutagenesis. The first 300 bp of tgpA were cloned into the suicide
vector pSC200 [31] downstream of PrhaB, a rhamnose inducible/
glucose repressible promoter, to give rise to pSC200-PA2873.
Upon transfer to PAO1, pSC200-PA2873 cointegration event
placed tgpA under PrhaB control. In both liquid and solid media, the
PAO1 PrhaB::tgpA strain showed a specific conditional growth
phenotype (Figure 4B), i.e. repression of PrhaB by glucose strongly
impairs growth, while rhamnose addition allows normal growth.
Due to the low number of cells in the inoculum of liquid media,
growth rate was undetectable by microtiter reader during the
initial half-time of the experiments (Figure 4B). The growth of
PAO1 PrhaB::tgpA in liquid M9-citrate supplemented with either
rhamnose or glucose was monitored for 7 hrs from inoculum by
titration of colony forming units per ml (CFU/ml) on LB plates. As
shown in Figure 4C, PAO1 PrhaB::tgpA in rhamnose started
Figure 3. Genetic organization and transcription analysis of the genomic region including PA2873 locus (tgpA). (A) PA2875-2874-2873-
2872 gene cluster is represented according to visualization by GBrowse in Pseudomonas Genome Database. Locations of fragments amplified by the
oligo pairs (Roman numbers) used in RT-PCR-based transcription analysis (B) are shown along the region map. The position of plasmid pDM4
cointegration in PAO1 PA2875::pDM4 strain is indicated. (B) Total RNA was extracted from PAO1 and PAO1 PA2875::pDM4 cells in both exponential
(E) and stationary (S) phases, and analyzed by RT-PCR. RT untreated samples (RT2) as controls of genomic DNA contamination were included in the
analysis.
doi:10.1371/journal.pone.0050323.g003
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Figure 4. Mutagenesis analysis of the PA2875-2874- tgpA gene cluster. (A) Each indicated locus was targeted for knock-out by homologous
recombination-mediated cointegration of the suicide vector pDM4 carrying chloramphenicol resistance (CmR). The dnaG gene for DNA primase and
the algR gene for a LytTR-type two-component response regulator were used respectively as positive and negative controls of essentiality.
Cointegration targeting was achieved by cloning internal 600–800 bp fragments of PA2875, PA2874, tgpA, dnaG and algR, respectively, into pDM4.
The resulting constructs were transferred from E. coli S17-lpir to PAO1 by conjugation, selecting cointegration events by plating the conjugation
mixtures on PIA supplemented with chloramphenicol. Three independent conjugation experiments were performed. Efficiency of cointegration in a
given locus is expressed as a percentage of CmR ex-conjugant colonies relative to the negative control algR. (B) The rhamnose inducible/glucose
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growing and the number of cells was detectable 11 hrs from
inoculum (Figure 4B). On the contrary, for PAO1 PrhaB::tgpA in
glucose only residual growth was observed (Figure 4C). In this
case, the threshold of cell number detection by the microtiter
reader was barely achieved in the 21 hrs of analysis (Figure 4B).
Some escape from glucose repression and/or the activity of TgpA,
which might have a low turn-over rate, may account for the
residual growth of the inoculum cells in a glucose-supplemented
medium.
Conclusions
Overall, the results presented above strongly indicate that TgpA
plays a critical role in the viability of P. aeruginosa. The
unambiguous prediction of the presence of six transmembrane
helices (Figure S3), our detection in membrane fractions (see
above) and the export across inner membrane found by PhoA
fusion screen [32] would strongly suggest that TgpA acts at a
cytoplasmic membrane level. Figure S3 shows that the TgpA
region TG180–544 containing the functional TG domain has a high
probability of being exposed on the outward face of cytoplasmic
membrane, i.e. to protrude into the periplasmic space. Therefore,
we suggest that TgpA takes part in an essential function linked to
the cell wall. Specific but non-essential functions at cell wall level
have been shown for some prokaryotic proteins endowed with TG
domains. In the Methanothermobacter species, prophage proteins
PeiW and PeiP act as pseudomurein endoisopeptidases [33,34]. In
the periplasm of B. bronchiseptica, WbmE protein catalyzes the
deamidation of uronamide-rich O chains of lipopolysaccharide
(LPS) [28]. It is conceivable that TgpA activity can participate in
cell wall functions such as i) assembly of peptidoglycan structures
ii) maturation/secretion of key periplasmic proteins iii) assembly of
surface polypeptide structures iv) biogenesis/maturation of LPS.
Supporting Information
Figure S1 Graphical representation of the distribution
across species of the structural TGase domain belonging
to the transglutaminase-like superfamily [17] (PF01841
in PFAM database [25]). The radius of the arc, i.e. distance
from the root node at the center of the sunburst, shows the
taxonomic level (‘‘superkingdom’’, ‘‘kingdom’’, etc). The length of
the arc represents the number of domains at a given level. Among
the 1752 species represented in the figure, we found 4842
sequences containing the TGase domain. 265 sequences, belong-
ing to 238 prokaryotic species, present a specific association of
TGase domain in front of the domain of unknown function
DUF3488 (PF11992 in PFAM database [25]) containing typically
6 transmembrane helices.
(TIF)
Figure S2 Graphical representation of the distribution
of DUF3488 across prokaryotic species. The radius of the
arc, i.e. distance from the root node at the center of the sunburst,
shows the taxonomic level (‘‘superkingdom’’, ‘‘kingdom’’, etc). The
length of the arc represents the number of domains represented at
a given level. Among the 238 species represented in the figure, 234
present the specific architecture of the DUF3488 domain followed
by TGase domain.
(TIF)
Figure S3 Prediction of transmembrane helices in TgpA
(PA2873). Transmembrane helice prediction along the 668 aa
sequence of PA2873 was performed by TMHMM Server v.2.0
(http://www.cbs.dtu.dk/services/TMHMM/) [35]. TMHMM
supplies some statistics and a list of the locations of the predicted
transmembrane helices and the predicted location of the
intervening loop regions. The prediction gives the most probable
location and orientation of transmembrane helices in the
sequence. It is found by an algorithm called N-best that sums
over all paths through the model with the same location and
direction of the helices. Some statistics are given as follows.
Length: the length of the protein sequence; Number of predicted
TMHs: the number of predicted transmembrane helices; Exp
number of AAs in TMHs: the expected number of amino acids in
transmembrane helices. If this number is larger than 18 it is very
likely to be a transmembrane protein (OR have a signal peptide);
Exp number, first 60 AAs: the expected number of amino acids in
transmembrane helices in the first 60 amino acids of the protein;
Total prob of N-in: The total probability that the N-term is on the
cytoplasmic side of the membrane; POSSIBLE N-term signal
sequence: a warning that is produced when ‘‘Exp number, first 60
AAs’’ is larger than 10. The plot shows the posterior probabilities
of inside/outside/TM helix. At the top of the plot (between 1 and
1.2) the N-best prediction is shown. Note the high probability of
outside location of the region spanning aa 180 to 544 containing
the functional TG domain.
(TIF)
Table S1 List of bacterial strains and plasmids.
(PDF)
Table S2 Oligonucleotides.
(PDF)
Table S3 TgpA peptides detected through MudPIT
analysis of membrane fractions.
(PDF)
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repressible promoter PrhaB was inserted upstream to tgpA giving rise to PAO1 PrhaB::tgpA strain. To test the repression effects of glucose on growth
rate, overnight cultures of PAO1 PrhaB:: tgpA in M9-citrate supplemented with rhamnose were diluted to OD600 = 10
26 and inoculated in microtiter
wells filled with 200 ml of M9-citrate supplemented with either rhamnose or glucose. Culture growth at 37u with stirring was monitored in real-time
by OD600 measurement in a microtiter reader for 21 hrs. Specificity of glucose/rhamnose effects on the growth of PAO1 PrhaB::tgpA was assessed by
monitoring the PAO1 cultures in M9-citrate supplemented with either rhamnose or glucose. Note the opposite effects of glucose on growth of PAO1
PrhaB::PA2873 and PAO1, respectively. In the insert, overnight cultures of PAO1 PrhaB::tgpA in M9-citrate supplemented with rhamnose were also
tested for growth on solid M9-citrate supplemented with either rhamnose or glucose, by spotting 2 ml of 10-fold serial dilutions, from OD600 = 1 (left)
to OD600 = 10
26 (right). (C) During the first 7 hrs from inoculum, a time window in which growth rate was undetectable by microtiter reader, the
growth of PAO1 PrhaB::tgpA in liquid M9-citrate supplemented with either rhamnose or glucose was monitored by titration of colony-forming units
per ml (CFU/ml) on LB plates.
doi:10.1371/journal.pone.0050323.g004
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